Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT03625622 · COMPLETED
Trial details
- NCT number
- NCT03625622
- Sponsor
- AriBio Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-12-22
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.